Abstract
INTRODUCTION
Screening for Alzheimer’s disease neuropathologic change (ADNC) in individuals with atypical presentations is challenging but essential for clinical management. We trained automatic speech-based classifiers to distinguish frontotemporal dementia (FTD) patients with ADNC from those with frontotemporal lobar degeneration (FTLD).
METHODS
We trained automatic classifiers with 99 speech features from 1 minute speech samples of 179 participants (ADNC = 36, FTLD = 60, healthy controls [HC] = 89). Patients’ pathology was assigned based on autopsy or cerebrospinal fluid analytes. Structural network-based magnetic resonance imaging analyses identified anatomical correlates of distinct speech features.
RESULTS
Our classifier showed 0.88 ±$ pm $ 0.03 area under the curve (AUC) for ADNC versus FTLD and 0.93 ±$ pm $ 0.04 AUC for patients versus HC. Noun frequency and pause rate correlated with gray matter volume loss in the limbic and salience networks, respectively.
DISCUSSION
Brief naturalistic speech samples can be used for screening FTD patients for underlying ADNC in vivo. This work supports the future development of digital assessment tools for FTD.
Highlights
We trained machine learning classifiers for frontotemporal dementia patients using natural speech.
We grouped participants by neuropathological diagnosis (autopsy) or cerebrospinal fluid biomarkers.
Classifiers well distinguished underlying pathology (Alzheimer’s disease vs. frontotemporal lobar degeneration) in patients.
We identified important features through an explainable artificial intelligence approach.
This work lays the groundwork for a speech-based neuropathology screening tool.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Sunghye Cho,
Christopher A. Olm,
Sharon Ash,
Sanjana Shellikeri,
Galit Agmon,
Katheryn A. Q. Cousins,
David J. Irwin,
Murray Grossman,
Mark Liberman,
Naomi Nevler | April 4, 2024